Estetrol for treatment of advanced ER+/HER2-breast cancer

被引：3
|
作者：
Schmidt, Marcus [1 ]
Hoenig, Arnd [2 ]
Zimmerman, Yvette [3 ]
Verhoeven, Carole [3 ]
Almstedt, Katrin [1 ]
Battista, Marco [1 ]
Lenhard, Hans Georg [2 ]
Krijgh, Jan [3 ]
Bennink, Herjan Coelingh [3 ]
机构：
[1] Univ Med Ctr, Mainz, Germany
[2] Catholic Hosp, Mainz, Germany
[3] Pantarhei Oncol, Zeist, Netherlands
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P5-11-15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-11-15
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Estetrol for treatment of advanced ER+ breast cancer
    Verhoeven, Carole
    Schmidt, Marcus
    Hoenig, Arnd
    Duennebacke, Jan
    Dutman, Ellen
    Krijgh, Jan
    Bennink, Herjan Coelingh
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [2] Estetrol for treatment of advanced ER+ breast cancer
    Schmidt, M.
    Honig, A.
    Verhoeven, C.
    Almstedt, K.
    Battista, M.
    Lenhard, H. G.
    Krijgh, J.
    Bennink, H. Coelingh
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [3] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [4] Dysregulated expression of repetitive DNA in ER+/HER2-breast cancer
    Yandim, Cihangir
    Karakulah, Gokhan
    [J]. CANCER GENETICS, 2019, 239 : 36 - 45
  • [5] Tumor infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Esposito, A.
    Viale, G.
    Curigliano, G.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [6] APOBEC driving genomic evolution in ER+/HER2-breast cancer
    Bos, M.
    Smid, M.
    Sleijfer, S.
    Martens, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S105 - S106
  • [7] Tumor-infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Vialel, G.
    Curigliano, G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 347 - 354
  • [8] Targeting of endocrine therapy-induced estrogen-receptor/HER2-cross-talk in circulating tumor cells from metastatic ER+/HER2-breast cancer: Implications for treatment of ER+/HER2-breast cancer
    Thaler, S.
    Rosswag, S.
    Pantel, K.
    Sleeman, J. P.
    Schmidt, M.
    Cotarelo, C. L.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [10] Predictive model algorithms identifying early and advanced stage ER+/HER2-breast cancer in claims data
    Beachler, Daniel C.
    de Luise, Cynthia
    Yin, Ruihua
    Gangemi, Kelsey
    Cochetti, Philip T.
    Lanes, Stephan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (02) : 171 - 178
12345